AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating FDA's Emergency Use Authorization
This chapter critically examines the implications of the FDA's emergency use authorization (EUA) process and its correlation to traditional drug regulatory pathways. It highlights the conflicts of interest arising from the FDA's substantial reliance on pharmaceutical industry funding, which compromises the integrity of drug approvals. The discussion further explores the potential need for reforms to ensure regulatory fairness and prioritize patient safety amidst the pressures exerted by big pharma.